Loading clinical trials...
Loading clinical trials...
PhaRmacOkinetics and PHarmacodynamic BiomarkErs of Janus Kinase Inhibitor Therapy in PatIents With Ulcerative Colitis (PROPHETIC)
Conditions
Interventions
Janus Kinase Inhibitor
Locations
1
Netherlands
Amsterdam Medical Center, IBD Center
Amsterdam, North Halland, Netherlands
Start Date
August 25, 2020
Primary Completion Date
December 15, 2020
Completion Date
December 2, 2021
Last Updated
January 4, 2022
NCT07271069
NCT06975722
NCT07185009
NCT07184996
NCT07245394
NCT07089420
Lead Sponsor
Alimentiv Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions